Overview

Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Status:
Recruiting
Trial end date:
2030-10-01
Target enrollment:
Participant gender:
Summary
Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis
Phase:
Phase 3
Details
Lead Sponsor:
Sherief Abd-Elsalam
Treatments:
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Alendronate